Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1350464
European Journal of Endocrinology, Vol 135, Issue 4, 464-468
Copyright © 1996 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinilla, L.
Right arrow Articles by Aguilar, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Pinilla, L.
Right arrow Articles by Aguilar, E.

Effects of N-methyl-D-aspartate and kainic acid on prolactin secretion in prepubertal female rats

Leonor Pinilla, Dolores González, Manuel Tena-Sempere, Rafaela Aguilar and Enrique Aguilar

Pinilla L, González D, Tena-Sempere M, Aguilar R, Aguilar E. Effects of N-methyl-D-aspartate and kainic acid on prolactin secretion in prepubertal female rats. Eur J Endocrinol 1996;135:464–8. ISSN 0804–4643

The control of prolactin (PRL) secretion by N-methyl-D-aspartate (NMDA) and kainic acid (KA), agonists of NMDA and kainate receptors, and the interactions between NMDA and KA with nitric oxide (NO) were analysed in prepubertal female rats. For this purpose, serum PRL concentrations and hypothalamic and pituitary dopamine (DA) and serotonin (5-HT) concentrations were measured in females injected with NMDA, KA or two blockers of NO synthase: Nw-nitro-L-arginine methyl ester (NAME) and Nw-nitro-L-arginine (NA). Also, the effects of combined administration of NMDA and KA with the blockers of NO synthase were analyzed. We found that PRL release was inhibited 15 min after NMDA and KA administration, an effect probably mediated through the release of hypothalamic DA, as shown by the higher pituitary DA concentrations after NMDA or KA administration. The inhibitory effect of NMDA was preceded by an increase in serum PRL levels, observed at 5 and 10 min after NMDA administration. Nw-Nitro-L-arginine methyl ester alone inhibited prolactin secretion, and both NAME and NA abolished the inhibitory effect of KA, but not that of NMDA. We conclude that administration of NMDA exerted a dual action on PRL secretion: initially DA release was inhibited, leading to an increase in PRL secretion that in turn stimulated DA release and decreased serum PRL concentrations. Kainic acid also inhibited PRL secretion by releasing DA, an effect blocked by NO synthase inhibitors.

Enrique Aguilar, Department of Physiology, Faculty of Medicine, University of Córdoba, E-14004, Spain




This article has been cited by other articles:


Home page
EndocrinologyHome page
G. D'Aniello, A. Tolino, A. D'Aniello, F. Errico, G. H. Fisher, and M. M. Di Fiore
The Role of D-Aspartic Acid and N-Methyl-D-Aspartic Acid in the Regulation of Prolactin Release
Endocrinology, October 1, 2000; 141(10): 3862 - 3870.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 European Society of Endocrinology.